Flector
Product Images NDC 21695-707

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Flector (NDC 21695-707). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Title Bar (3c9f9507 8f72 4850 Aa43 9ff5532f1396 01)

Flector Patch 1.3% topical patch label showing the proprietary name, active ingredient diclofenac epolamine, concentration 1.3%, prescription only status, and labeler Rebel Distributors Corp. The label displays minimal text with a clear indication of the product type and use.*

FDA Label Image

Chemical Structure (3c9f9507 8f72 4850 Aa43 9ff5532f1396 02)

Chemical structure diagram showing the molecular formulas of Diclofenac and Epolamine. Diclofenac is depicted with two chlorine atoms and a carboxylate group, while Epolamine is shown as 2-(pyrrolidin-1-yl)ethanol with structural details of nitrogen and hydroxyl groups.*

FDA Label Image

Study Graph 1 (3c9f9507 8f72 4850 Aa43 9ff5532f1396 03)

A line graph depicting percentages of patients achieving various levels of pain relief by day 3 in a 14-day study. The x-axis shows percent improvement from baseline (10% to 100%), and the y-axis shows percent of patients improved (0% to 100%). Two lines represent Diclofenac Patch and Placebo, illustrating that the Diclofenac Patch group had higher percentages of pain relief at each improvement level compared to Placebo.*

FDA Label Image

Study Graph 2 (3c9f9507 8f72 4850 Aa43 9ff5532f1396 04)

A line graph titled 'Patients Achieving Various Levels of Pain Relief at End of Study; 14-Day Study' showing percent of patients improved versus percent improvement from baseline. Two lines compare Diclofenac Patch and Placebo, with Diclofenac Patch consistently showing higher patient improvement percentages across all levels.*

FDA Label Image

Study Graph 3 (3c9f9507 8f72 4850 Aa43 9ff5532f1396 05)

A line graph titled 'Patients Achieving Various Levels of Pain Relief at Day 3; 7-Day Study' comparing percent improvement in pain relief from baseline between two groups: Diclofenac Patch and Placebo. The graph displays percent of patients improved on the vertical axis and percent improvement from baseline on the horizontal axis with the Diclofenac Patch group showing higher pain relief percentages than the Placebo group across improvement levels.*

FDA Label Image

Study Graph 4 (3c9f9507 8f72 4850 Aa43 9ff5532f1396 06)

A line graph showing the percentage of patients achieving various levels of pain relief at the end of a 7-day study. The graph compares results for a Diclofenac Patch versus a placebo, illustrating patient improvement percentages along both axes.*

FDA Label Image

Flector 1.3% (3c9f9507 8f72 4850 Aa43 9ff5532f1396 07)

Label for Flector 1.3% patch, each patch containing 180mg diclofenac epolamine in an aqueous base with 1.3% active ingredient. The label includes Barcode, NDC 21695-707-01, lot number, expiration date, and manufacturer Teikoku Seiyaku Co., Ltd. It is distributed by Physician Partner, Thousand Oaks, CA, with storage instructions for controlled room temperature.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.